These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18357378)

  • 1. Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
    Wong RP; Khosravi S; Martinka M; Li G
    Oncol Rep; 2008 Apr; 19(4):933-7. PubMed ID: 18357378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
    Batinac T; Hadzisejdić I; Brumini G; Ruzić A; Vojniković B; Zamolo G
    Coll Antropol; 2007 Jan; 31 Suppl 1():17-22. PubMed ID: 17469743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL; Martinka M; Li G
    J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
    Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of apoptosis regulators in cutaneous malignant melanoma.
    Tang L; Tron VA; Reed JC; Mah KJ; Krajewska M; Li G; Zhou X; Ho VC; Trotter MJ
    Clin Cancer Res; 1998 Aug; 4(8):1865-71. PubMed ID: 9717813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p53 is a late event in the development of malignant melanoma.
    Lassam NJ; From L; Kahn HJ
    Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
    J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
    Touab M; Arumi-Uría M; Barranco C; Bassols A
    Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.
    Vetter CS; Müller-Blech K; Schrama D; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Jul; 297(1):26-30. PubMed ID: 15906050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
    Zhang H
    Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.